학술논문
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Document Type
Article
Author
Abhishek, A.; Valdes, A.M.; Nguyen-Van-Tam, J.S.; Williams, H.C.; Boyton, R.J.; Altmann, D.M.; Peckham, N.; Coates, L.C.; Barber, V.; Cureton, L.; Francis, A.; Appelbe, D.; Eldridge, L.; Julier, P.; Rombach, I.; Cook, J.A.; McKnight, Á.; Bluett, J.; Brooks, T.; Pande, I.; Seng Tang, T.; Tran, G.; Layton, A.; Price, E.; Whittam, L.; Venkatachalam, S.; Hawarden, A.; Huws, G.; Pratt, A.; Reynolds, N.J.; Walsh, D.; Joseph, T.; Mathew, R.; Oikonomou, S.; Gwynne, C.; Crowder, R.; Saravanan, V.; Mustafa, A.; Tacu, C.; Batty, T.; George, E.; Soni, A.; Horton, S.; Madan, A.; Gaffney, K.; Lapin, A.; Bingham, S.; Levell, N.; Lim, E.; Gullick, N.; Holroyd, C.; Khalid, S.; Lwin, M.; Green, M.; Hunt, L.; Alcorn, N.; Ellis, R.; Hider, S.; Hassan, A.; Youngstein, T.; Douglas, K.; Ho, G.N.; Levasseur, K.; Treacy, S.; Cheila, M.; Pradeep, J.; Rhys-Dillon, C.; Jones, C.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, September 2022, 10(9):840-850)
Subject
Language
English
ISSN
22132619
22132600
22132600